ArticleJAMA ophthalmology2017
Controversies in Using Off-Label Intravitreous Bevacizumab for Patients With Diabetic Macular Edema-Reply.
Neil M Bressler et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleJAMA ophthalmology2017
Neil M Bressler et al.PubMed ↗Publisher ↗
No numbers read from the abstract.